« Previous
Next »
Urology
Volume 68, Issue 6
, Pages 1193-1197
, December 2006
Persistence of therapeutic effect after repeated injections of botulinum toxin type A to treat incontinence due to neurogenic detrusor overactivity
References
- Factors involved in the success of antimuscarinic treatment. BJU Int. 1999;83(Suppl 2):42–47
- Long-term results of augmentation cystoplasty in spinal cord injury patients. Spinal Cord. 2000;38:490–494
- . The neuroparalytic and hemaglutining activity of botulinum toxin. In: Simpson LL editors. Neuropoisons: Their Pathophysiological Actions. New York: Plenum Press; 1971;p. 303–324
- Effect of botulinum toxin A on the autonomic nervous system of the rat lower urinary tract. J Urol. 2003;169:1896–1900
- Decreased sensory receptors P2X3 and TRPV1 in suburothelial nerve fibers following intradetrusor injections of botulinum toxin for human detrusor overactivity. J Urol. 2005;174:977–983
- Botulinum-A toxin for treating detrusor hyperreflexia in spinal cord injured patients: a new alternative to anticholinergic drugs? (Preliminary results). J Urol. 2000;164:692–697
- European experience of 200 cases treated with botulinum-A toxin injections into the detrusor muscle for urinary incontinence due to neurogenic detrusor overactivity. Eur Urol. 2004;45:510–515
- Botulinum toxin type A is a safe and effective treatment for neurogenic urinary incontinence: results of a single treatment, randomized, placebo controlled 6-month study. J Urol. 2005;174:196–200
- Good urodynamic practices: uroflowmetry, filling cystometry, and pressure-flow studies. Neurourol Urodyn. 2002;21:261–274
- The standardization of terminology in neurogenic lower urinary tract dysfunction: with suggestions for diagnostic procedures. Neurourol Urodyn. 1999;18:139–158
- The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-Committee of the International Continence Society. Neurourol Urodyn. 2002;21:167–178
- Transient paralysis of the bladder due to wound botulism. Eur Urol. 2001;39:610–612
- Axotomy-like changes in cat motoneuron electrical properties elicited by botulinum toxin depend on the complete elimination of neuromuscular transmission. J Neurosci. 1991;11:657–666
- . Botulinum-induced alteration of nerve-muscle interactions in the human orbicularis oculi following treatment for blepharospasm. Neurology. 1991;41:1800–1805
- Functional repair of motor endplates after botulinum neurotoxin type A poisoning: biphasic switch of synaptic activity between nerve sprouts and their parent terminals. Proc Natl Acad Sci USA. 1999;96:3200–3205
- Motor nerve sprouting in human orbicularis muscle after botulinum A injection. Invest Ophthalmol Vis Sci. 1990;31:964–967
- Botulinum-A toxin as a treatment of detrusor-sphincter dyssynergia: a prospective study in 24 spinal cord injury patients. J Urol. 1996;155:1023–1029
- . Treatment of detrusor-sphincter dyssynergia with botulinum A toxin: a double-blind study. Arch Phys Med Rehabil. 1990;71:24–26
- Treatment of patients with achalasia with botulinum toxin: a multicenter prospective cohort study. Dis Esophagus. 2003;16:204–209
- . Success of repeat detrusor injections of botulinum a toxin in patients with severe neurogenic detrusor overactivity and incontinence. Eur Urol. 2005;47:653–659
- Lack of ultrastructural detrusor changes following endoscopic injection of botulinum toxin type a in overactive neurogenic bladder. Eur Urol. 2004;46:784–791
- . Effects of repeated botulinum toxin injections on orbicularis oculi muscle. J Clin Neuroophthalmol. 1992;12:121–127
- . Botulinum toxin and its applications in the lower urinary tract. BJU Int. 2004;93:702–706
- Repeated botulinum-A toxin injections in treatment of children with neurogenic detrusor overactivity. Urology. 2005;66:865–870
PII: S0090-4295(06)02064-4
doi: 10.1016/j.urology.2006.08.1069
© 2006 Elsevier Inc. All rights reserved.
« Previous
Next »
Urology
Volume 68, Issue 6
, Pages 1193-1197
, December 2006
